Searched for
GLENMARK BREAKOUT
Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
Ahead of Market: 10 things that will decide stock market action on WednesdayNifty 50 and BSE Sensex declined amid selling in banking, auto and IT stocks. Markets remain range-bound, awaiting triggers, with analysts ...
Nifty finds support: Nagaraj Shetti spots 2 breakout stocks worth watchingNifty's Monday pullback is a technical dip, not a trend reversal, says HDFC Securities analyst Nagaraj Shetti. After forming a higher botto...
Two Trades for Today: A pharma major for a 6% upmove, a mid-cap healthcare stock for a gain of about 5%Our technical analysts identify select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.
Positive on market; buy these 2 stocks now: Rajesh BhosaleAngel One's Rajesh Bhosale is optimistic about the market. He advises holding a positive view above 24,700. The targets are 25,000 and 25,2...
Two Trades for Today: A large-cap pharma stock for almost 5% gain; a mid-cap IT solutions provider for 6% upmoveSelect stocks gain momentum even in volatile markets.
Daily Trading Desk: 2 trades for short-term gains; a private insurer for 7.4% gain, a large-cap pharma stock for 6% upmoveSelect stocks gain momentum even in volatile markets.
Big movers on D-Street: What should investors do with ONGC, Glenmark Pharma and Reliance Power?The domestic market saw a significant boost as the Sensex surged 384 points to a new high of 84,928, and Nifty reached a record peak of 25,...
Buy Glenmark Pharmaceuticals, target price Rs 720: Motilal Oswal Financial ServicesMaking higher lows from the last six months which suggests continuous strength and a fresh breakout.
Stock Radar: This pharma company sees breakout after 6-month consolidation; time to buy?Short-term traders can look to buy the stock now or on dips for a possible target of Rs 474 in the next 4-6 weeks, suggested experts
Buy Glenmark Pharma, target price Rs 670: EdelweissGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 17756.84 Crore) operating in ...
Buy Glenmark Pharmaceuticals, target price Rs 622: Chandan TapariaGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 16690.25 Crore) operating in ...
Buy Glenmark Pharma, target price Rs 517: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 14390.58 Crore) operating in ...
- Buy Glenmark Pharma with a target of 540: Prakash Gaba
Glenmark Pharma is a ‘Buy’ call with a stop loss of below 505.
- Buy Glenmark Pharma for target of Rs 395: Aptart
Glenmark Pharma has seen a price and volume breakout.
- Expect Glenmark Pharma to touch Rs 415: Edelweiss
Edelweiss is of the view that charts of Glenmark Pharma indicate a bullish pattern. It expects the stock to move higher to Rs 415 levels.
- Have a target of around 360 on Glenmark: Hemant Kale, Maia Financial Services
Glenmark has given a long term consolidation breakout last week.
- Buy Glenmark Pharma for target of Rs 310-316: Religare
Glenmark Pharma has broken out on comparatively higher volume.
- Buy Glenmark Pharma for target of Rs 305: APTART
Price breakout with volume seen on the charts.